News

Ovarian cancer is one of the most lethal malignancies of the female reproductive system, primarily because of its asymptomatic nature during the early stages of oncogenesis. Using PathoChip we have examined the microbiome of ovarian tumors. These studies have established unique microbiome signatures in ovarian cancer comprising a distinct group of viruses, bacteria, fungi and [...]

PHILADELPHIA - Cancer is a result of normal cellular functions going wildly awry on a genetic level. That fact has been known for some time, but increasing evidence is showing that the human microbiome, the diverse population of microorganisms within every person, may play a key role in either setting the stage for cancer or [...]

PHILADELPHIA — Erle S. Robertson Ph.D., professor of Microbiology at the Perelman School of Medicine, University of Pennsylvania, has been awarded $1.4 million from the Avon Foundation to develop technology for identifying microbial signatures in breast and ovarian cancers. “About 20 percent of human cancers are associated with infectious agents. With the increase in technology [...]